Del Bufalo D - Search Results

1

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.

Fontemaggi G, Dell'Orso S, Trisciuoglio D, Shay T, Melucci E, Fazi F, Terrenato I, Mottolese M, Muti P, Domany E, Del Bufalo D, Strano S, Blandino G. Fontemaggi G, et al. Among authors: del bufalo d. Nat Struct Mol Biol. 2009 Oct;16(10):1086-93. doi: 10.1038/nsmb.1669. Epub 2009 Sep 27. Nat Struct Mol Biol. 2009. PMID: 19783986

2

Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.

Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, Zupi G. Leonetti C, et al. Among authors: del bufalo d. Clin Cancer Res. 1999 Sep;5(9):2588-95. Clin Cancer Res. 1999. PMID: 10499637

3

Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line.

Biroccio A, Candiloro A, Mottolese M, Sapora O, Albini A, Zupi G, Del Bufalo D. Biroccio A, et al. Among authors: del bufalo d. FASEB J. 2000 Apr;14(5):652-60. doi: 10.1096/fasebj.14.5.652. FASEB J. 2000. PMID: 10744622

4

Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.

Del Bufalo D, Trisciuoglio D, Biroccio A, Marcocci L, Buglioni S, Candiloro A, Scarsella M, Leonetti C, Zupi G. Del Bufalo D, et al. J Cell Biochem. 2001 Aug 21-Sep 5;83(3):473-83. doi: 10.1002/jcb.1245. J Cell Biochem. 2001. PMID: 11596115

5

relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.

Ricca A, Biroccio A, Trisciuoglio D, Cippitelli M, Zupi G, Del Bufalo D. Ricca A, et al. Among authors: del bufalo d. Br J Cancer. 2001 Dec 14;85(12):1914-21. doi: 10.1054/bjoc.2001.2174. Br J Cancer. 2001. PMID: 11747334 Free PMC article.

6

Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation.

Del Bufalo D, Di Castro V, Biroccio A, Varmi M, Salani D, Rosanò L, Trisciuoglio D, Spinella F, Bagnato A. Del Bufalo D, et al. Mol Pharmacol. 2002 Mar;61(3):524-32. doi: 10.1124/mol.61.3.524. Mol Pharmacol. 2002. PMID: 11854432

7

Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.

Biroccio A, Amodei S, Benassi B, Scarsella M, Cianciulli A, Mottolese M, Del Bufalo D, Leonetti C, Zupi G. Biroccio A, et al. Among authors: del bufalo d. Oncogene. 2002 May 2;21(19):3011-9. doi: 10.1038/sj.onc.1205415. Oncogene. 2002. PMID: 12082531

8

Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity.

Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G, Del Bufalo D. Iervolino A, et al. Among authors: del bufalo d. FASEB J. 2002 Sep;16(11):1453-5. doi: 10.1096/fj.02-0122fje. Epub 2002 Jul 1. FASEB J. 2002. PMID: 12205045

9

Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used.

Del Bufalo D, Biroccio A, Trisciuoglio D, Bruno T, Floridi A, Aquino A, Zupi G. Del Bufalo D, et al. Eur J Cancer. 2002 Dec;38(18):2455-62. doi: 10.1016/s0959-8049(02)00391-x. Eur J Cancer. 2002. PMID: 12460791

10

Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity.

Del Bufalo D, Trisciuoglio D, Scarsella M, Zangemeister-Wittke U, Zupi G. Del Bufalo D, et al. Oncogene. 2003 Nov 20;22(52):8441-7. doi: 10.1038/sj.onc.1206999. Oncogene. 2003. PMID: 14627985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters